# TB-500: How Sourcing Quality Is Judged

**By TelosRX Editorial Team** · 2026-09-21

**Sourcing quality for TB-500 comes down to three things: where the raw peptide originates, how a pharmacy tests it, and what regulatory category it currently sits in. Telos rx does not sell standalone TB-500. Its only TB-500 offering is the BPC-157 + TB-500 combination protocol, prepared by partner compounding pharmacies for patients who are approved after an online evaluation.**

The short answer

**Good sourcing means verified raw material, a pharmacy that tests every batch, and a clear paper trail from supplier to prescription.** Because the FDA classified TB-500 as a Category 2 bulk substance, it cannot legally be compounded or dispensed on its own right now. Telos rx addresses this by offering TB-500 only inside the [BPC-157 + TB-500 combination protocol](https://www.telosrx.com/pages/bpc-157-tb500), sourced and tested through partner compounding pharmacies.

[Start your BPC-157 + TB-500 combination visit →](https://start.telosrx.com/start-online-visit/peptides)

## Why sourcing matters more for peptides than most supplements

Peptides like TB-500 are synthesized, not extracted from a plant or a simple chemical reaction. Small errors in the manufacturing process can leave behind incomplete sequences, solvent residue, or bacterial contamination. Because peptides are usually injected rather than swallowed, anything that would normally be filtered out by digestion goes straight into the bloodstream instead.

That is why the sourcing question is not academic. A raw material lot that looks fine on a certificate of analysis from an unverified vendor can still carry impurities a compounding pharmacy's own testing would catch. Patients researching TB-500 online will find a wide range of sellers, and the gap between the best and worst of them is large.

## What "verified sourcing" actually involves

When a legitimate compounding pharmacy sources a peptide, the process typically includes a few consistent steps. The pharmacy qualifies its raw material supplier, requests a certificate of analysis for each lot, and in many cases runs independent third-party testing rather than trusting the supplier's paperwork alone. The finished preparation is then tested again for identity, purity, sterility, and potency before it reaches a patient.

None of this is optional under federal compounding rules. Partner compounding pharmacies that work with telos rx are required to document this chain for every batch they release. That is part of why the pharmacy relationship matters as much as the peptide itself.

**Key takeaway:** Sourcing quality is judged by supplier verification, batch-level testing, and regulatory compliance, not by marketing claims on a product page.

## The regulatory layer: why TB-500 is not sold alone

In late 2023, the FDA placed TB-500 on its Category 2 bulk substance list. That category flags substances the agency has significant safety concerns about for compounding. As a result, compounding pharmacies are restricted from preparing or dispensing TB-500 as a standalone peptide. You can read the FDA's own overview of how bulk substance compounding rules work on its [compounding questions and answers page](https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers).

This restriction is a major reason sourcing quality varies so widely across the internet. Because standalone TB-500 cannot move through a licensed pharmacy channel, most of what is sold online as "research grade" TB-500 comes from unregulated vendors operating entirely outside pharmacy oversight. There is no requirement that these vendors test their material, disclose their supply chain, or meet sterility standards.

Telos rx's answer to this gap is the BPC-157 + TB-500 combination protocol. It is a distinct, separately reviewed offering that a partner compounding pharmacy can legally prepare. It goes through the same sourcing and testing chain as any other compounded product on the platform.

## Red flags in how TB-500 is commonly sold

Patients researching TB-500 sourcing should watch for a few recurring patterns. Vendors that will not name their supplier or provide a current certificate of analysis are common warning signs. So is a listing that describes its product only as "for research purposes" while marketing it for personal use, or one that never mentions the current FDA bulk substance restriction at all. That omission usually means the seller is not operating inside compounding rules to begin with.

Price is a weaker signal than people expect. A low price does not necessarily mean poor sourcing, and a high price does not guarantee good sourcing. The more reliable signals are documentation, testing transparency, and whether the seller is a licensed pharmacy at all.

## How the combination protocol is structured differently

Because telos rx only offers TB-500 through the combination protocol, every step is tied to a licensed process. A patient completes an online intake, a licensed provider reviews the submission asynchronously, and if approved, a partner compounding pharmacy prepares the BPC-157 + TB-500 combination and ships it directly. Every preparation carries the sourcing and testing standards that apply to compounded medication generally, and the LegitScript certification that telos rx holds reflects an ongoing review of exactly these practices.

This is a different experience from ordering a vial from a website with no license, no provider review, and no compounding oversight. The tradeoff is that telos rx cannot offer standalone TB-500 while the current bulk substance restriction stands, only the reviewed combination protocol.

## How testing actually protects patients

Testing is not a single checkbox. A thorough compounding pharmacy runs identity testing to confirm the vial actually contains TB-500 and not a different peptide or a filler substance. It runs purity testing to measure how much of the material is the intended peptide versus breakdown products or synthesis byproducts. It runs sterility and endotoxin testing to confirm the preparation is safe for injection, and potency testing to confirm the labeled strength matches what is actually in the vial.

Skipping any one of these steps can produce a product that looks identical to a properly tested one. A vial of clear liquid with a printed label reveals almost nothing about what actually happened during manufacturing. That is the core problem with judging sourcing quality from the outside. Patients cannot see testing results in a product photo, so the pharmacy's process and its willingness to be transparent about that process become the real signal.

This is also why regulatory status and testing quality are linked rather than separate issues. A pharmacy operating inside compounding rules has a legal obligation to document its testing. A vendor operating outside those rules, selling a peptide the FDA currently restricts from standalone compounding, has no such obligation and often no license that could be revoked if it cut corners.

## How to read a certificate of analysis

A certificate of analysis, often called a COA, lists the tests run on a specific batch and the results. A useful COA names the testing lab and shows a batch or lot number that matches the product received. It reports specific values for identity, purity, and contaminants rather than vague pass or fail statements. It should also carry a recent date, since a COA from an old batch tells a patient nothing about the batch currently being sold.

Patients evaluating any peptide source, not just TB-500, can reasonably expect this level of documentation from a legitimate compounding pharmacy. If a seller cannot produce a specific, dated, lab-attributed COA on request, that alone is a reason to be cautious, regardless of how professional the website looks.

## What patients can reasonably ask a source

Before trusting any TB-500 source, it is reasonable to ask direct questions. Is the seller a licensed pharmacy? Who verifies the raw material? Is there batch-specific testing, and how is a patient's dose reviewed by a provider before it ships? A source that cannot answer these clearly, or that avoids the regulatory question entirely, has not earned the trust that peptide sourcing requires.

TB-500 is derived from a peptide fragment called thymosin beta-4. For a broader look at how the underlying research on thymosin beta-4 has developed over time, the NIH's PMC database maintains a searchable index at [its thymosin beta-4 search results page](https://www.ncbi.nlm.nih.gov/pmc/?term=thymosin+beta+4).

Patients already working with telos rx for other conditions can compare this sourcing model against other available products. That includes [BPC-157](https://www.telosrx.com/pages/bpc-157) on its own, [sermorelin](https://www.telosrx.com/pages/sermorelin), or [NAD+ nasal spray](https://www.telosrx.com/pages/nad-nasal-spray), all of which move through the same licensed, tested pharmacy process.

[Start your BPC-157 + TB-500 combination visit →](https://start.telosrx.com/start-online-visit/peptides)

## Frequently Asked Questions

### Does telos rx sell TB-500 by itself?

No. Telos rx only offers TB-500 as part of the BPC-157 + TB-500 combination protocol, prepared by partner compounding pharmacies for approved patients.

### Why can't compounding pharmacies prepare standalone TB-500 right now?

The FDA classified TB-500 as a Category 2 bulk substance in late 2023, which restricts compounding pharmacies from preparing or dispensing it on its own.

### What does good sourcing look like for a compounded peptide?

Verified raw material suppliers, a current certificate of analysis for each lot, independent testing where possible, and finished-product testing for identity, purity, sterility, and potency before dispensing.

### Are online sellers of standalone TB-500 operating through licensed pharmacies?

Generally no. Because standalone TB-500 cannot currently move through a licensed compounding pharmacy channel, most sellers offering it operate outside pharmacy oversight and testing requirements.

### Is the BPC-157 + TB-500 combination protocol reviewed the same way as other telos rx products?

Yes. It goes through an online intake, asynchronous provider review, and preparation by partner compounding pharmacies, the same process used for other compounded products on the platform.

### Where can I read more about the science behind TB-500?

TB-500 is derived from thymosin beta-4, and published research on that peptide fragment can be found through the NIH's PMC search database.

_TelosRX is LegitScript-certified. Compounded medication is not FDA-approved and is prepared under federal compounding regulations. This article is general information, not medical advice, and does not replace guidance from your own provider. Approval is subject to evaluation by a licensed provider, and approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service._

Questions about sourcing or eligibility? [Learn more about the BPC-157 + TB-500 combination protocol](https://www.telosrx.com/pages/bpc-157-tb500) or visit [TelosRX](https://telosrx.com).

**Tags:** bpc-157, peptides, tb-500

---

> Source: [Telos RX](https://www.telosrx.com/blogs/glp1/tb-500-how-sourcing-quality-is-judged)